HuMax is an abbreviation for "human monoclonal antibody targeting", used by the pharmaceutical company Genmab in trade names. Examples include:

• HuMax-CD4 (zanolimumab)

• HuMax-CD20 (ofatumumab)

• HuMax-EGFr (zalutumumab)